National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

7.3 Major clinical issues with psychosis and cannabis/ hallucinogen use

prev pageTOC |next page

Table of contents

7.3.1 Effects of cannabis and other hallucinogens on psychiatric disorders

7.3.2 Interactions between cannabis and other hallucinogens and therapeutic agents for psychotic disorders

Top of page

7.3.3 Management approaches to comorbid psychotic disorders and cannabis use


Initial assessment


prev pageTOC |next page